A recent study of the etiology of sector RP across a variety of genotypes was conducted by Georgiou et al. [19], including RHO variants, and suggested that any progression that was noted up to 6 years of follow-up was small in extent with little clinical impact. The gene discussed is RHO; the disease is retinitis pigmentosa 1.